公开(公告)号：US12215159B2

公开(公告)日：2025-02-04

申请号：US18582950

申请日：2024-02-21

Applicant: Immunitas Therapeutics, Inc.

Inventor： Alison Tisdale ,  Uli Bialucha ,  George Punkosdy ,  Alexandria Fusco ,  Frano Irvine ,  Emily Rosentrater ,  Elizabeth Scanlon ,  Michael Battles

IPC: C07K16/00 ,  A61P35/00 ,  A61P37/04 ,  C07K16/28 ,  G01N33/68 ,  A61K39/00

Abstract: The invention relates generally to anti-CD161 antibodies, pharmaceutical compositions comprising such antibodies, and methods of using such antibodies for treating disorders associated with or mediated by CD161, for example, certain cancers. In addition, the invention also relates to expression vectors and host cells for making these antibodies.

公开(公告)号：US20240279346A1

公开(公告)日：2024-08-22

申请号：US18582950

申请日：2024-02-21

Applicant: Immunitas Therapeutics, Inc.

Inventor： Alison TISDALE ,  Uli BIALUCHA ,  George PUNKOSDY ,  Alexandria FUSCO ,  Frano IRVINE ,  Emily ROSENTRATER ,  Elizabeth SCANLON ,  Michael BATTLES

IPC: C07K16/28 ,  A61K39/00 ,  A61P35/00 ,  A61P37/04 ,  G01N33/68

CPC classification number: C07K16/2851 ,  A61P35/00 ,  A61P37/04 ,  G01N33/6854 ,  A61K2039/505 ,  C07K2317/52 ,  C07K2317/565 ,  G01N2333/70596 ,  G01N2800/52

Abstract: The invention relates generally to anti-CD161 antibodies, pharmaceutical compositions comprising such antibodies, and methods of using such antibodies for treating disorders associated with or mediated by CD161, for example, certain cancers. In addition, the invention also relates to expression vectors and host cells for making these antibodies